An innovative AI model provides a powerful and cost-effective alternative to genetic testing by analyzing routine pathology slides to predict a patient's response to kidney cancer therapy, thereby ...

Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...

Casdatifan (Cas) monotherapy in patients (pts) with previously treated clear cell renal cell carcinoma (ccRCC): Safety, efficacy and subgroup analysis across multiple doses from ARC-20, a phase 1 open ...

Early-stage kidney cancer is often asymptomatic and discovered incidentally through imaging tests for unrelated conditions. Treatment options include partial nephrectomy, radical nephrectomy, ...

Kidney cancer treatment has shifted towards active surveillance and minimally invasive surgeries, improving patient outcomes and preserving kidney function. Robotic surgical techniques, including ...